4//SEC Filing
Happel David 4
Accession 0001104659-23-120372
CIK 0001400118other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:21 PM ET
Size
5.1 KB
Accession
0001104659-23-120372
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Award
Series A Common Stock
2023-11-17+624,910→ 625,500 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001623567
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 4:21 PM ET
- Size
- 5.1 KB